| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $117K | — |
| Cost of Revenue | $95K | — |
| Gross Profit | $22K | — |
| R&D Expense | $1.8M | -19.0% |
| SG&A Expense | $4.8M | -3.9% |
| Operating Income | -$6.6M | +8.9% |
| Net Income | -$6.5M | +7.1% |
| EPS (Basic) | -$0.63 | +25.9% |
| EPS (Diluted) | -$0.63 | +25.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.2M | -59.8% |
| Current Assets | $2.6M | -53.4% |
| Total Assets | $2.8M | -49.4% |
| Current Liabilities | $672K | +14.3% |
| Total Liabilities | $672K | +14.3% |
| Stockholders' Equity | $2.1M | -57.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.5M | +1.6% |
| Financing Cash Flow | $2.4M | -71.8% |